Gene replacement therapy is gaining FDA approval in several therapeutic areas. In this roundtable discussion, three clinicians explain the different types of gene therapy and discuss risks and clinical trial results using spinal muscular atrophy (SMA) as an example.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.